News
Innovative CAR-T cell therapy achieves remarkable results in patients with refractory CD30+ lymphoma
Researchers from the Sant Pau Research Institute (IR Sant Pau), in collaboration with Sant Pau Hospital and the Josep Carreras Leukaemia Research Institute, have developed an innovative CAR-T cell ...
Researchers from the Sant Pau Research Institute (IR Sant Pau), in collaboration with Sant Pau Hospital and the Josep ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback